November 24, 2014 by Brad Perriello
Stryker is free to make an offer for Smith & Nephew after a 6-month no-bid period elapsed last week, fueling speculation that the U.S orthopedics giant will move on its British rival.
Under British law Stryker was barred from bidding on Smith & Nephew after demurring in May. Read more
November 20, 2014 by MassDevice
Boston Scientific should pay Johnson & Johnson $7.23 billion in damages and interest for breach of contract, nearly 9 years after Boston Scientific won a controversial bidding war for device maker Guidant, lawyers for J&J told a U.S. federal judge today.
“To be blunt about it, Guidant cheated – and then it lied to Johnson & Johnson so Johnson & Johnson would not discover what Guidant had done,” attorney Harold Weinberger said at the start of a non-jury trial in Manhattan federal court. Read more
November 20, 2014 by Brian Johnson
Allergan has been around these parts since there were more orange groves in Orange County, Calif., than pink Rolls Royces.
For 60 years the medical aesthetics giant has called Orange County home, with Irvine serving as a centerpoint for the robust medical technology sector that has sprung up around it and become one of the top-performing medtech clusters in the world. Read more
November 21, 2014 by Mark Hollmer
Becton Dickinson’s $12.2 billion bid for device maker CareFusion cleared a big regulatory hurdle this week.
The New Jersey medical equipment maker disclosed that the required waiting period under U.S. antitrust regulations expired Nov. 19. Read more
November 24, 2014 by MassDevice
U.S. medical device maker Stryker is examining a bid for Britain’s Smith & Nephew as a regulatory restriction barring an offer comes to an end, Bloomberg reported today, citing unnamed sources.
Shares of Smith & Nephew, which makes artificial knees and hips, rose as much as 10%. Read more